INVO Fertility Debt to Equity Ratio 2010-2025 | IVF
Current and historical debt to equity ratio values for INVO Fertility (IVF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. INVO Fertility debt/equity for the three months ending March 31, 2025 was 0.00.
| INVO Fertility Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.02B | $0.01B | 3.34 |
| 2024-12-31 | $0.03B | $0.02B | 1.30 |
| 2024-09-30 | $0.02B | $0.00B | -731.45 |
| 2024-06-30 | $0.02B | $0.00B | 12.02 |
| 2024-03-31 | $0.02B | $0.00B | 1794.86 |
| 2023-12-31 | $0.02B | $0.00B | 19.73 |
| 2023-09-30 | $0.02B | $0.00B | 51.24 |
| 2023-06-30 | $0.01B | $0.00B | -4.89 |
| 2023-03-31 | $0.01B | $0.00B | 68.51 |
| 2022-12-31 | $0.01B | $0.00B | -4.80 |
| 2022-09-30 | $0.00B | $0.00B | 2.63 |
| 2022-06-30 | $0.00B | $0.00B | 0.91 |
| 2022-03-31 | $0.00B | $0.01B | 0.52 |
| 2021-12-31 | $0.00B | $0.01B | 0.43 |
| 2021-09-30 | $0.01B | $0.00B | 2.46 |
| 2021-06-30 | $0.01B | $0.00B | 1.28 |
| 2021-03-31 | $0.01B | $0.01B | 0.82 |
| 2020-12-31 | $0.01B | $0.01B | 0.91 |
| 2020-09-30 | $0.01B | $0.00B | -1.43 |
| 2020-06-30 | $0.01B | $0.00B | -1.64 |
| 2020-03-31 | $0.01B | $0.00B | -1.22 |
| 2019-12-31 | $0.01B | $0.00B | -1.48 |
| 2019-09-30 | $0.01B | $0.00B | -1.68 |
| 2019-06-30 | $0.01B | $0.00B | -2.08 |
| 2019-03-31 | $0.01B | $0.00B | -2.13 |
| 2018-12-31 | $0.00B | $0.00B | -1.29 |
| 2018-09-30 | $0.01B | $0.00B | -1.21 |
| 2018-06-30 | $0.01B | $0.00B | -1.28 |
| 2018-03-31 | $0.01B | $-0.01B | -1.06 |
| 2017-12-31 | $0.01B | $-0.01B | -1.05 |
| 2017-09-30 | $0.01B | $-0.01B | -1.04 |
| 2017-06-30 | $0.01B | $-0.01B | -1.04 |
| 2017-03-31 | $0.01B | $-0.01B | -1.04 |
| 2016-12-31 | $0.01B | $-0.01B | -1.06 |
| 2016-09-30 | $0.01B | $0.00B | -1.09 |
| 2016-06-30 | $0.01B | $0.00B | -1.11 |
| 2016-03-31 | $0.00B | $0.00B | -1.14 |
| 2015-12-31 | $0.00B | $0.00B | -1.15 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | $0.00B | -1.04 |
| 2011-09-30 | $0.00B | $0.00B | -1.05 |
| 2011-06-30 | $0.00B | $0.00B | -1.05 |
| 2011-03-31 | $0.00B | $0.00B | -1.06 |
| 2010-12-31 | $0.00B | $0.00B | -1.07 |
| 2010-09-30 | $0.00B | $0.00B | -1.07 |
| 2010-06-30 | $0.00B | $0.00B | -1.08 |
| 2010-03-31 | $0.00B | $0.00B | -1.09 |
| 2009-12-31 | $0.00B | $0.00B | -1.09 |
| 2009-09-30 | $0.01B | $-0.01B | -1.10 |
| 2009-06-30 | $0.00B | $0.00B | -1.18 |
| 2009-03-31 | $0.00B | $0.00B | -1.28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| CVS Health (CVS) | United States | $76.787B | 9.54 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.279B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Revvity (RVTY) | United States | $12.220B | 21.03 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.72 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |